Androderm Lawsuit | Androderm Testosterone Side Effects : Heart Attacks, Strokes, Cardiovascular Problems

Androderm Lawsuit | Androderm Testosterone Side Effects : Heart Attacks, Strokes, Cardiovascular Problems

Androderm Lawsuits, Androderm Heart Attack, Androderm Stroke, Androderm Heart Problems, Androderm Testosterone Lawsuit, Androderm Class Action Lawsuit

Wright & Schulte LLC is investigating Androderm lawsuits on behalf of men who may have suffered severe cardiovascular side effects due to using the testosterone drug. Androderm, a testosterone transdermal patch, has been linked to stroke, heart attack and other severe side effects in men who used the product for low testosterone treatment. Androderm is one of the testosterone replacement therapies under review by the U.S. Food & Drug Administration (FDA). In January 2014, the federal agency announced its plan to re-evaluate the safety of low testosterone drugs based on research suggesting an increased risk of cardiovascular problems among users. Since the FDA’s announcement, Androderm and other testosterone treatment therapy lawsuits have been filed on behalf of men who allegedly suffered life-threatening injuries from using the drugs.

Men who have suffered a stroke, heart attack or other cardiovascular problem while using Androderm may want to consider filing an Androderm lawsuit. Wright & Schulte LLC is offering free Androderm lawsuit evaluations to men who have been harmed by this drug and want to learn about the legal options available to them. For more information, please contact Wright & Schulte LLC as soon as possible for a free Androderm lawsuit consultation with one of our attorneys.

What is Androderm?

Androderm is a prescription medication approved by the U.S. Food & Drug Administration (FDA) in 1995 to treat hypogonadism, also known as low testosterone, in men who lack or have low testosterone due to an underlying medical condition. Androderm, manufactured by Actavis Pharmaceuticals, is a patch gel containing testosterone that is applied once a day to the upper arms, back, abdomen and thighs, according to the official Androderm website. USA Today reported that Androderm, a popular low testosterone treatment therapy, had $87 million in sales in 2011. Androderm is not a medication that all men should take, according to the product’s website, particularly if they have breast cancer, known or suspected prostate cancer or if they have a pre-existing cardiac, renal or hepatic disease.
[androderm.com/hcp/think/convenient/application.asp]
[usatoday30.usatoday.com/money/business/story/2012/09/10/testosterone-gets-marketing-push-but-long-term-unknown/57715666/1, September 10, 2010]

The FDA stated in January 2014 that the agency will reassess all FDA-approved testosterone treatment products based on two studies showing the potential health risks to its users. A study published in the November 2013 Journal of the American Medical Association, found that older men who had an underlying cardiovascular disease and took prescription testosterone treatment medication had a 30 percent increased risk of having a stroke, heart attack, or death, over the men who did not take testosterone medication. A second study showed men 65 years and older and younger men with pre-existing heart disease who took prescribed testosterone therapy, had a higher risk of having a heart attack within the first 90 days after taking the first prescription. The FDA’s drug safety guide also warns that accidental exposure to testosterone gel can cause early puberty in young children because the gel can transfer from a man’s body to others.
[fda.gov/downloads/drugs/drugsafety/ucm294248.pdf]
[fda.gov/Drugs/DrugSafety/ucm383904.htm, January 31, 2014]

Androderm and Testosterone Treatment Lawsuits

In the wake of the FDA’s safety announcement, lawsuits have been filed by plaintiffs seeking compensation for serious health problems allegedly caused by testosterone treatment therapies, including Androderm. The lawsuits contend that low testosterone treatment medication cause such side effects as:

  • Heart attack
  • Heart Failure
  • Stroke
  • Deep vein thrombosis
  • Pulmonary embolism

Court records indicate that in April 2014, a lawsuit was filed on behalf of an Albany County, New York man who was prescribed Androderm by his doctor and suffered a stroke in April 2011, allegedly as a result of taking the low testosterone treatment product. The lawsuit further alleges that the man has not fully regained his ability to speak and his memory was badly damaged due to the stroke. The complaint further contended that the Androderm advertisements of defendants Actavis Pharmaceuticals, Watson Laboratories, and Physicians Total Care, which manufactures and distributes Androderm, did not disclose the cardiac and stroke side effects linked with the gel patch medication. The lawsuit was filed in the U.S. District Court for the District of Nevada (Case No: 2:14-cv-00596)

Court documents also show that the rising number of lawsuits has prompted the filing of a motion that asked the U.S. Judicial Panel on Multidistrict Litigation (JPML) to transfer all lawsuits involving testosterone treatment therapies to the U.S. District Court, Eastern District of Louisiana. The plaintiffs’ motion contends that there are 50 lawsuits filed across the country involving such low testosterone treatment medications as Androderm, AndroGel, Axiron, Delatestryl, Depo-Testosterone, Fortesta, Striant, Testim, and Testopel, and the complaints should be consolidated since they all allege that the prescription drugs cause heart attacks, strokes and other life-threatening side-effects. (In Re: Testosterone Products Liability Litigation, No. 42, JPML) The JPML has not yet announced whether it will hear oral arguments on this request. However, the federal panel has scheduled a hearing on May 29, 2014, for oral arguments on a motion to transfer and consolidate more than 38 AndroGel lawsuits to the U.S. District Court, Northern District of Illinois for coordinated pretrial hearings. (In Re: AndroGel Product Liability Litigation, No. 36, JPML)

Wright & Schulte LLC Offers Legal Consultations To Androderm Victims

Wright & Schulte LLC is offering free, no-obligation Androderm lawsuit consultations to victims who suffered serious side effects related to the use of this low testosterone therapy, as well as their families. To explore your legal options, please contact Wright & Schulte LLC today by completing the online form on the right, or call toll free, 1-800-399-0795.

Print